• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2016 Fiscal Year Final Research Report

Evaluation of TYRO3 as a therapeutic target in breast and lung cancers

Research Project

  • PDF
Project/Area Number 26460627
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Applied pharmacology
Research InstitutionKobe University

Principal Investigator

Minami Hironobu  神戸大学, 医学研究科, 教授 (60450574)

Project Period (FY) 2014-04-01 – 2017-03-31
Keywords乳癌 / 肺癌 / TYRO3 / Gas6
Outline of Final Research Achievements

The expression of TYRO3 and Gas6 was investigated using RNA in situ hybridization in clinical tumor samples of breast and lung cancers. Both TYRO3 and Gas6 was highly expressed in luminal A breast cancer cells, but not in luminal B type or triple negative breast cancer. HER2-positive breast cancer expressed no or weak expression. These results support our hypothesis that inhibition of TYRO3 can be a therapeutic strategy for hormone receptor-positive breast cancer.
TYRO3 was expressed in some of lung cancers, but no apparent relationship was observed between the expression of TYRO3 and EGFR mutations or ALK status.

Free Research Field

腫瘍内科学

URL: 

Published: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi